NYSE:BAX - Baxter International Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Baxter International Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $81.55 -1.62 (-1.95 %) (As of 12/9/2019 04:00 PM ET) Add Compare Today's Range$81.40Now: $81.55▼$83.1350-Day Range$76.39MA: $80.92▼$88.7252-Week Range$61.40Now: $81.55▼$89.93Volume2.96 million shsAverage Volume2.74 million shsMarket Capitalization$41.64 billionP/E Ratio26.74Dividend Yield1.06%Beta0.98 ProfileAnalyst RatingsAdvanced ChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:BAX Previous Symbol CUSIP07181310 CIK10456 Webhttp://www.baxter.com/ Phone224-948-2000Debt Debt-to-Equity Ratio0.72 Current Ratio2.78 Quick Ratio2.10Price-To-Earnings Trailing P/E Ratio26.74 Forward P/E Ratio24.20 P/E Growth2.14 Sales & Book Value Annual Sales$11.13 billion Price / Sales3.74 Cash Flow$4.52 per share Price / Cash Flow18.06 Book Value$14.69 per share Price / Book5.55Profitability EPS (Most Recent Fiscal Year)$3.05 Net Income$1.62 billion Net Margins13.80% Return on Equity22.99% Return on Assets10.82%Miscellaneous Employees50,000 Outstanding Shares510,556,000Market Cap$41.64 billion Next Earnings Date2/6/2020 (Estimated) OptionableOptionable Receive BAX News and Ratings via Email Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter. BAX Rates by TradingView Baxter International (NYSE:BAX) Frequently Asked Questions What is Baxter International's stock symbol? Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX." How often does Baxter International pay dividends? What is the dividend yield for Baxter International? Baxter International declared a quarterly dividend on Tuesday, November 19th. Stockholders of record on Friday, December 6th will be given a dividend of $0.22 per share on Thursday, January 2nd. This represents a $0.88 annualized dividend and a dividend yield of 1.08%. The ex-dividend date is Thursday, December 5th. View Baxter International's Dividend History. How will Baxter International's stock buyback program work? Baxter International announced that its board has authorized a stock buyback plan on Tuesday, November 13th 2018, which allows the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 6.1% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board of directors believes its stock is undervalued. How were Baxter International's earnings last quarter? Baxter International Inc (NYSE:BAX) released its quarterly earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 earnings per share for the quarter, topping analysts' consensus estimates of $0.74 by $0.06. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to analysts' expectations of $2.79 billion. Baxter International had a return on equity of 22.99% and a net margin of 13.80%. Baxter International's revenue was up 2.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.64 EPS. View Baxter International's Earnings History. When is Baxter International's next earnings date? Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Baxter International. What price target have analysts set for BAX? 13 Wall Street analysts have issued twelve-month price objectives for Baxter International's shares. Their forecasts range from $75.00 to $109.00. On average, they expect Baxter International's share price to reach $90.08 in the next year. This suggests a possible upside of 10.5% from the stock's current price. View Analyst Price Targets for Baxter International. What is the consensus analysts' recommendation for Baxter International? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International. Has Baxter International been receiving favorable news coverage? News coverage about BAX stock has trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Baxter International earned a daily sentiment score of -1.7 on InfoTrie's scale. They also gave news articles about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Baxter International. Are investors shorting Baxter International? Baxter International saw a decline in short interest in the month of October. As of October 31st, there was short interest totalling 5,490,000 shares, a decline of 16.9% from the September 30th total of 6,610,000 shares. Based on an average daily trading volume, of 2,830,000 shares, the short-interest ratio is presently 1.9 days. Currently, 1.1% of the company's stock are short sold. View Baxter International's Current Options Chain. Who are some of Baxter International's key competitors? Some companies that are related to Baxter International include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Steris (STE), Varian Medical Systems (VAR) and Insulet (PODD). What other stocks do shareholders of Baxter International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), BlackRock (BLK), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Endologix (ELGX), Honeywell International (HON), Verizon Communications (VZ), Home Depot (HD), Pfizer (PFE) and AT&T (T). Who are Baxter International's key executives? Baxter International's management team includes the folowing people: Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)Mr. James K. Saccaro, Exec. VP & CFO (Age 46)Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)Mr. Giuseppe Accogli, Sr. VP & Pres of Americas (Age 48)Mr. Scott Pleau, Sr. VP of Operations (Age 53) Who are Baxter International's major shareholders? Baxter International's stock is owned by many different of institutional and retail investors. Top institutional investors include State Street Corp (4.74%), Third Point LLC (3.30%), Veritas Asset Management LLP (1.25%), California Public Employees Retirement System (0.74%), Voya Investment Management LLC (0.59%) and Sumitomo Mitsui Trust Holdings Inc. (0.39%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International. Which major investors are selling Baxter International stock? BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, Veritas Asset Management LLP, Man Group plc, State of New Jersey Common Pension Fund D, Voya Investment Management LLC, First Trust Advisors LP, Alberta Investment Management Corp and Stifel Financial Corp. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International. Which major investors are buying Baxter International stock? BAX stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Kornitzer Capital Management Inc. KS, California Public Employees Retirement System, Teacher Retirement System of Texas, Squarepoint Ops LLC, Dalton Greiner Hartman Maher & Co., State of Alaska Department of Revenue and Varma Mutual Pension Insurance Co. View Insider Buying and Selling for Baxter International. How do I buy shares of Baxter International? Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Baxter International's stock price today? One share of BAX stock can currently be purchased for approximately $81.55. How big of a company is Baxter International? Baxter International has a market capitalization of $41.64 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International. What is Baxter International's official website? The official website for Baxter International is http://www.baxter.com/. How can I contact Baxter International? Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected] MarketBeat Community Rating for Baxter International (NYSE BAX)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 633 (Vote Outperform)Underperform Votes: 557 (Vote Underperform)Total Votes: 1,190MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/9/2019 by MarketBeat.com StaffFeatured Article: Dividend Yield